CoChat

Change in Plasma Cytokine Levels During Risperidone Treatment in Children with Autism

Open access
Choi, Jae Eun, Widjaja, Felicia, Careaga, Milo, Bent, Stephen, Ashwood, Paul, Hendren, Robert L. · 2014 · Journal of Child and Adolescent Psychopharmacology
Cited by 31

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Atypical antipsychotics decrease irritability in autism. They also affect the cytokine network. Psychological stress, depression, and, possibly, autism spectrum disorder (ASD) are associated with the production of pro-inflammatory cytokines. We sought to determine if risperidone treatment led to changes in plasma cytokine levels. METHODS: Forty-five subjects from an open-label study of risperidone treatment of children and adolescents with ASD, ages 4-18 years, had an analysis of 27 different cytokines at baseline and after 8 weeks of treatment using multiplex assays (Millipore) and read on the Luminex 100(™) platform. We examined changes in each of the cytokine levels in the entire group, and also compared changes in cytokines in responders versus nonresponders. RESULTS: After 8 weeks of risperidone treatment, 2 of the 27 plasma cytokines showed statistically significant decreases in median levels: Eotaxin (p=0.0003) and monocyte chemoattractant protein-1 (MCP-1) (p=0.0024). Six of the 48 subjects met two criteria for responders to risperidone, and the median values of interleukin (IL)-5 were significantly higher (p=0.005) in the overall responder group than in nonresponders. CONCLUSIONS: Two cytokines, eotaxin and MCP-1, which have previously been identified as abnormally elevated in children with autism, decreased during treatment with risperidone. This suggests a possible mechanism of action of risperidone treatment and a balancing of the immune system in affected subjects in this very preliminary study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2013.0108

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Neuroglial activation and neuroinflammation in the brain of patients with autism

    Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 9×

    “Their results are consistent with data from other studies that showed an increase in protein levels of MCP-1 and eotaxin in brain specimens from individuals with ASD (Vargas et al. 2005) or for pro-inflammatory cytokines in the blood of ASD children (Ashwood et al. 2011a).”
    Influential
  • Risperidone in Children with Autism and Serious Behavioral Problems

    McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 2×

    “Using the same parameters as McCracken et al. (2002), subjects were defined as overall responders to treatment if they had a decrease in ABC-I ‡ 25% and a Clinical Global Impressions-Improvement (CGI-I) rating of ‘‘very much improved’’ or ‘‘much PLASMA CYTOKINE LEVELS DURING RISPERIDONE TREATMENT…”
  • The immune response in autism: a new frontier for autism research

    Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 9×

    “Their results are consistent with data from other studies that showed an increase in protein levels of MCP-1 and eotaxin in brain specimens from individuals with ASD (Vargas et al. 2005) or for pro-inflammatory cytokines in the blood of ASD children (Ashwood et al. 2011a).”
    InfluentialSelf-citation
  • Differential monocyte responses to TLR ligands in children with autism spectrum disorders

    Enstrom, A. M., Onore, C. E., Van de Water, J. A., & Ashwood, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.001 · Cited by 294 · cited 1×

    “There are a limited number of studies finding an association be-tween treatment and immune response in autism spectrum disorder (ASD) (Ashwood et al. 2006; Enstrom et al. 2010; Gupta et al. 1998).”
    Self-citation
  • Altered T cell responses in children with autism

    Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281 · cited 9×

    “Their results are consistent with data from other studies that showed an increase in protein levels of MCP-1 and eotaxin in brain specimens from individuals with ASD (Vargas et al. 2005) or for pro-inflammatory cytokines in the blood of ASD children (Ashwood et al. 2011a).”
    InfluentialSelf-citation
  • Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders

    Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279 · cited 9×

    “Their results are consistent with data from other studies that showed an increase in protein levels of MCP-1 and eotaxin in brain specimens from individuals with ASD (Vargas et al. 2005) or for pro-inflammatory cytokines in the blood of ASD children (Ashwood et al. 2011a).”
    InfluentialSelf-citation
  • Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism

    Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00021-6 · Cited by 250 · cited 1×

    “There are a limited number of studies finding an association be-tween treatment and immune response in autism spectrum disorder (ASD) (Ashwood et al. 2006; Enstrom et al. 2010; Gupta et al. 1998).”
  • A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder

    Bent, S., Bertoglio, K., Ashwood, P., Bostrom, A., & Hendren, R. L. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1078-8 · Cited by 156 · cited 1×

    “Previous studies investigating inflammatory abnormalities related to ASD have yielded conflicting and inconclusive results (Bent et al. 2011; Onore et al. 2012).”
    Self-citation
  • Impact of antipsychotics on cytokine production in-vitro

    Himmerich, H., Schönherr, J., Fulda, S., Sheldrick, A. J., Bauer, K., & Sack, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.04.009 · Cited by 104 · cited 1×

    “There are a growing number of studies reporting that psychological stress, psychosis, or depression are associated with the production of pro-inflammatory cytokines, and that treatment with antipsychotic drugs affects the cytokine network (Himmerich et al. 2011; Na et al. 2014).”

Show all 9 references

Cited by

Metadata

Authors
Choi, J. E., Widjaja, F., Careaga, M., Bent, S., Ashwood, P., & Hendren, R. L.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2014-12
Volume
24
Issue
10
Pages
586-589
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2045395905
Cited by
31
References
9
FWCI
1.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.